EVALUATION OF GANCICLOVIR FOR CYTOMEGALO-VIRUS DISEASE

[1] EFFECT OF LEUKOCYTE INTERFERON ON URINARY-EXCRETION OF CYTOMEGALOVIRUS BY INFANTS [J]. JOURNAL OF INFECTIOUS DISEASES, 1976, 133 : A205 - A210

[2] ACTIVATION BY THYMIDINE KINASE AND POTENT ANTIHERPETIC ACTIVITY OF 2'-NOR-2'-DEOXYGUANOSINE (2'NDG) [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1982, 108 (04) : 1716 - 1721

[3] BREAKTHROUGH OF CYTOMEGALOVIRUS-INFECTION DESPITE 9-(1,3-DIHYDROXY-2-PROPOXYMETHYL)GUANINE THERAPY [J]. ANNALS OF INTERNAL MEDICINE, 1986, 104 (04) : 587 - 587

[4] ACYCLOVIR IN IMMUNOCOMPROMISED PATIENTS WITH CYTOMEGALOVIRUS DISEASE - A CONTROLLED TRIAL AT ONE INSTITUTION [J]. AMERICAN JOURNAL OF MEDICINE, 1982, 73 (1A) : 241 - 248

[5] Balfour Jr H.H., 1988, ANTIMICROBIAL AGENTS, P345

[6] A HUMAN CYTOMEGALOVIRUS MUTANT RESISTANT TO THE NUCLEOSIDE ANALOG 9-([2-HYDROXY-1-(HYDROXYMETHYL)ETHOXY]METHYL)GUANINE (BW B759U) INDUCES REDUCED LEVELS OF BW B759U TRIPHOSPHATE [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (22) : 8769 - 8773

[7] METABOLIC-ACTIVATION OF THE NUCLEOSIDE ANALOG 9-([2-HYDROXY-L-(HYDROXYMETHYL)ETHOXY]METHYL)GUANINE IN HUMAN-DIPLOID FIBROBLASTS INFECTED WITH HUMAN CYTOMEGALO-VIRUS [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (08) : 2473 - 2477

[8] BLUM MR, 1982, AM J MED, V73, P186

[9] BOEHME RE, 1984, J BIOL CHEM, V259, P2346

[10] 9-(1,3-DIHYDROXY-2-PROPOXYMETHYL) GUANINE (GANCICLOVIR) IN THE TREATMENT OF CYTOMEGALOVIRUS GASTROINTESTINAL-DISEASE WITH THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME [J]. ANNALS OF INTERNAL MEDICINE, 1987, 107 (02) : 133 - 137

[1] EFFECT OF LEUKOCYTE INTERFERON ON URINARY-EXCRETION OF CYTOMEGALOVIRUS BY INFANTS [J]. JOURNAL OF INFECTIOUS DISEASES, 1976, 133 : A205 - A210

[2] ACTIVATION BY THYMIDINE KINASE AND POTENT ANTIHERPETIC ACTIVITY OF 2'-NOR-2'-DEOXYGUANOSINE (2'NDG) [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1982, 108 (04) : 1716 - 1721

[3] BREAKTHROUGH OF CYTOMEGALOVIRUS-INFECTION DESPITE 9-(1,3-DIHYDROXY-2-PROPOXYMETHYL)GUANINE THERAPY [J]. ANNALS OF INTERNAL MEDICINE, 1986, 104 (04) : 587 - 587

[4] ACYCLOVIR IN IMMUNOCOMPROMISED PATIENTS WITH CYTOMEGALOVIRUS DISEASE - A CONTROLLED TRIAL AT ONE INSTITUTION [J]. AMERICAN JOURNAL OF MEDICINE, 1982, 73 (1A) : 241 - 248

[5] Balfour Jr H.H., 1988, ANTIMICROBIAL AGENTS, P345

[6] A HUMAN CYTOMEGALOVIRUS MUTANT RESISTANT TO THE NUCLEOSIDE ANALOG 9-([2-HYDROXY-1-(HYDROXYMETHYL)ETHOXY]METHYL)GUANINE (BW B759U) INDUCES REDUCED LEVELS OF BW B759U TRIPHOSPHATE [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (22) : 8769 - 8773

[7] METABOLIC-ACTIVATION OF THE NUCLEOSIDE ANALOG 9-([2-HYDROXY-L-(HYDROXYMETHYL)ETHOXY]METHYL)GUANINE IN HUMAN-DIPLOID FIBROBLASTS INFECTED WITH HUMAN CYTOMEGALO-VIRUS [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (08) : 2473 - 2477

[8] BLUM MR, 1982, AM J MED, V73, P186

[9] BOEHME RE, 1984, J BIOL CHEM, V259, P2346

[10] 9-(1,3-DIHYDROXY-2-PROPOXYMETHYL) GUANINE (GANCICLOVIR) IN THE TREATMENT OF CYTOMEGALOVIRUS GASTROINTESTINAL-DISEASE WITH THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME [J]. ANNALS OF INTERNAL MEDICINE, 1987, 107 (02) : 133 - 137